Marcus Lind

493 total citations
25 papers, 278 citations indexed

About

Marcus Lind is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Marcus Lind has authored 25 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 13 papers in Internal Medicine and 6 papers in Epidemiology. Recurrent topics in Marcus Lind's work include Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Alcohol Consumption and Health Effects (4 papers). Marcus Lind is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Alcohol Consumption and Health Effects (4 papers). Marcus Lind collaborates with scholars based in Sweden and Netherlands. Marcus Lind's co-authors include Lars Johansson, Jan‐Håkan Jansson, Lars Johansson, Torbjörn K. Nilsson, Kurt Boman, Maria Wennberg, Jan-Håkan Jansson, Marie Eriksson, Lisbeth Slunga Järvholm and Anders Själander and has published in prestigious journals such as Stroke, Thrombosis and Haemostasis and Journal of Internal Medicine.

In The Last Decade

Marcus Lind

22 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Lind Sweden 12 150 137 55 53 34 25 278
D. Poli Italy 8 113 0.8× 186 1.4× 64 1.2× 68 1.3× 45 1.3× 19 353
R. G. J. Westendorp Netherlands 9 46 0.3× 62 0.5× 45 0.8× 53 1.0× 81 2.4× 10 356
Ma José Garcı́a-Cortes Spain 9 95 0.6× 307 2.2× 88 1.6× 11 0.2× 18 0.5× 9 391
K. Scott Brimble Canada 8 28 0.2× 77 0.6× 29 0.5× 43 0.8× 33 1.0× 10 250
Sandra Marten Germany 8 263 1.8× 342 2.5× 23 0.4× 81 1.5× 52 1.5× 24 425
Susan M. Shea United States 13 28 0.2× 32 0.2× 20 0.4× 93 1.8× 56 1.6× 36 386
S. K. Rushton-Smith United Kingdom 10 246 1.6× 670 4.9× 133 2.4× 7 0.1× 50 1.5× 14 720
Daniela Pogliani Italy 7 96 0.6× 463 3.4× 74 1.3× 10 0.2× 35 1.0× 9 575
Elio Melillo Italy 8 158 1.1× 157 1.1× 36 0.7× 29 0.5× 128 3.8× 17 348
Adrian W. Messerli United States 10 21 0.1× 121 0.9× 33 0.6× 7 0.1× 84 2.5× 41 253

Countries citing papers authored by Marcus Lind

Since Specialization
Citations

This map shows the geographic impact of Marcus Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Lind more than expected).

Fields of papers citing papers by Marcus Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Lind. The network helps show where Marcus Lind may publish in the future.

Co-authorship network of co-authors of Marcus Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Lind. A scholar is included among the top collaborators of Marcus Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Lind. Marcus Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Själander, Anders, et al.. (2025). A prospective study of the association between phosphatidylethanol concentration and risk of first-ever venous thromboembolism. European Journal of Internal Medicine. 142. 106436–106436.
2.
Jansson, Jan‐Håkan, et al.. (2025). Elevated levels of PAI-1 precede the occurrence of type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 17(1). 61–61.
3.
Lind, Marcus, et al.. (2024). Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden. Thrombosis Journal. 22(1). 77–77. 1 indexed citations
4.
Johansson, Lars, et al.. (2024). Incidence of Recurrent Venous Thromboembolism in a Population-Based Cohort. Clinical and Applied Thrombosis/Hemostasis. 30. 3005474841–3005474841.
5.
Lind, Marcus, et al.. (2023). Diabetes, prediabetes, and atrial fibrillation—A population‐based cohort study based on national and regional registers. Journal of Internal Medicine. 294(5). 605–615. 5 indexed citations
6.
Johansson, Lars, et al.. (2023). The association between self-rated health, health-related quality of life, and risk of venous thromboembolism. Preventive Medicine Reports. 36. 102434–102434. 3 indexed citations
7.
Lind, Marcus, et al.. (2022). Incidence and risk factors of venous thromboembolism in men and women. Thrombosis Research. 214. 82–86. 16 indexed citations
8.
Johansson, Lars, et al.. (2021). Factor XII Concentrations and Risk of Intracerebral Haemorrhage. A Prospective Case-Referent Study. Journal of Stroke and Cerebrovascular Diseases. 30(3). 105565–105565. 2 indexed citations
9.
Lind, Marcus, et al.. (2020). Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study. European Journal of Internal Medicine. 76. 50–57. 17 indexed citations
10.
Lind, Marcus, et al.. (2020). Weight, height, weight change, and risk of incident atrial fibrillation in middle‐aged men and women. Journal of Arrhythmia. 36(6). 974–981. 8 indexed citations
11.
Jansson, Jan‐Håkan, et al.. (2018). Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries. Clinical Epidemiology. Volume 10. 1215–1221. 42 indexed citations
13.
Jansson, Jan‐Håkan, Lars Johansson, Torbjörn K. Nilsson, et al.. (2017). Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study. Cerebrovascular Diseases Extra. 7(1). 84–94. 13 indexed citations
14.
Lind, Marcus, Jan‐Håkan Jansson, Torbjörn K. Nilsson, & Lars Johansson. (2016). High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment. Clinical Chemistry and Laboratory Medicine (CCLM). 54(12). 1981–1986. 6 indexed citations
15.
Lind, Marcus, Lars Johansson, Torbjörn K. Nilsson, Jan‐Håkan Jansson, & Martine J. Hollestelle. (2015). von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulants. Thrombosis Research. 136(5). 878–882. 3 indexed citations
16.
Johansson, Lars, et al.. (2014). Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study. Thrombosis Journal. 12(1). 6–6. 33 indexed citations
17.
Lind, Marcus, Kurt Boman, Lars Johansson, et al.. (2014). d-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment. Clinical Biochemistry. 47(7-8). 570–573. 11 indexed citations
18.
Lind, Marcus, Jan‐Håkan Jansson, Torbjörn K. Nilsson, Lisbeth Slunga Järvholm, & Lars Johansson. (2013). Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment. Thrombosis Research. 132(2). e77–e82. 2 indexed citations
19.
Lind, Marcus, Kurt Boman, Lars Johansson, et al.. (2011). Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. Journal of Internal Medicine. 271(3). 239–246. 13 indexed citations
20.
Lind, Marcus, Kurt Boman, Lars Johansson, et al.. (2009). Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment. Archives of Internal Medicine. 169(13). 1210–1210. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026